Figure 9 — Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia

Research Paper|Volume 13, Issue 12|pp. 16445–16470

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia

Back to articleFigure 9(9 of 13)

100%

Figure 9.The differential expression of critical genes in clinical samples between AML and healthy individuals. The result of clinical validation showed that ITGB2-AS, ITGAM, and PPBP are significantly higher in the initial diagnosed AML. ^***P < 0.001; ^*P < 0.05.